Biotech behind 2022’s largest local IPO delays norovirus vaccine

HilleVax Inc., the biotech that pulled off Boston's largest IPO of 2022, is delaying its norovirus vaccine by several months. CEO Rob Hershbeg cited logistical issues as reason for the delay.

Top 10 home sales in the Triad for the week of March 31

Hōm Wood Fired Grill to close at Bayshore Town Center

Coral Gables office site could be redeveloped as mixed use

Iron District soccer team to play one tier below Major League Soccer, first game in 2025

Micron pledges $40B U.S. expansion with signing of CHIPS Act

OHA brings in reinforcements for children’s hospitals struggling with RSV

UG2 passes its de-facto predecessor in size in its home state

Exclusive: Donohoe Cos. acquires Borger to grow its D.C.-area multifamily business

Biotech behind 2022’s largest local IPO delays norovirus vaccine

Previous Exclusive: Lendlease halts work on $1B S.F. mixed-use tower again, this time citing market conditions

Next Definitive Healthcare acquires Populi for $52 million

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

SRS Real Estate Partners opens first Hawaii office

Oregon Business & Industry: ‘Stunning rise’ in biz taxes makes climate increasingly difficult

Biz: Housing prices finally cool in NC mountains; Roy Williams aids First Tee

Billionaire Sternlicht resigns from Cano Health board, criticizes CEO

Austin energy entrepreneur Bud Brigham taking another company public

Patti Payne’s Cool Pads: Philanthropist puts Lake Sammamish waterfront mansion up for sale

MENU

FirstStar Group

More Stories

Chief executive of chickpeas: Charles Hanna carries on family business at Cedar’s

Previous Exclusive: Lendlease halts work on $1B S.F. mixed-use tower again, this time citing market conditions

Next Definitive Healthcare acquires Populi for $52 million

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories